CORNERSTONE BIOPHARMA HOLDINGS,
INC.
Nonstatutory Stock Option
Agreement
Granted Under 2005 Stock Incentive Plan
This agreement
evidences the grant by Cornerstone BioPharma Holdings, Inc., a
Delaware corporation (the “Company”), on [Grant
Date] (the “Grant Date”) to [Participant]
(the “Participant”), of an option to purchase, in whole
or in part, on the terms provided herein and in the Company’s
2005 Stock Incentive Plan (the “Plan”), a total of
[Number] shares (the “Shares”) of common stock,
$0.0001 par value per share, of the Company (“Common
Stock”) at $ [Option Price] per Share. Unless earlier
terminated, this option shall expire at 5:00 p.m., Eastern time, on
[Final Exercise Date] (the “Final Exercise
Date”).
It is intended
that the option evidenced by this agreement shall not be an
incentive stock option as defined in Section 422 of the
Internal Revenue Code of 1986, as amended, and any regulations
promulgated thereunder (the “Code”). Except as
otherwise indicated by the context, the term
“Participant”, as used in this option, shall be deemed
to include any person who acquires the right to exercise this
option validly under its terms.
(a) Form
of Exercise . Each election to exercise this option shall be in
writing, signed by the Participant, and received by the Company at
its principal office, accompanied by this agreement, and payment in
full in the manner provided in the Plan. The Participant may
purchase less than the number of shares covered hereby, provided
that no partial exercise of this option may be for any fractional
share.
(b)
Continuous Relationship with the Company Required . Except
as otherwise provided in this Section 3, this option may not
be exercised unless the Participant, at the time he or she
exercises this option, is, and has been at all times since the
Grant Date, an employee, or officer or director of, or consultant
or advisor to, the Company or any other entity the employees,
officers, directors, consultants or advisors of which are eligible
to receive option grants under the Plan (an “Eligible
Participant”).
(c)
Termination of Relationship with the Company . If the
Participant ceases to be an Eligible Participant for any reason,
then, except as provided in paragraphs (d) and (e) below,
the right to exercise this option shall terminate three months
after such cessation (but in no event after the Final Exercise
Date), provided that this option shall be exercisable
only to the extent that the Participant was entitled to exercise
this option on the date of such cessation. Notwithstanding the
foregoing, if the Participant, prior to the Final Exercise Date,
violates the
|
|
|
|
|
1
|
|
Insert
appropriate time-based vesting schedule.
|
non-competition
or confidentiality provisions of any employment contract,
confidentiality and nondisclosure agreement or other agreement
between the Participant and the Company, the right to exercise this
option shall terminate immediately upon such violation.
(d)
Exercise Period Upon Death or Disability . If the
Participant dies or becomes disa
|